Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$493,708,029
+$12,218,184 QoQ
Shares Held
1,943,962
-1.3% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#103
of 4,690 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $3,769,908,119 across 17 Drug Manufacturers - General names. JNJ ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,750,788 | $2,099,947,825 | |
| 2 | ABBV |
AbbVie Inc.
|
2,151,394 | $541,376,786 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
1,943,962 | $493,708,029 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,500,619 | $192,829,541 | |
| 5 | AMGN |
Amgen Inc
|
438,431 | $158,764,633 | |
| 6 | PFE |
Pfizer Inc
|
4,509,295 | $108,583,823 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
719,424 | $90,892,028 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,140,161 | $65,696,076 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,708,029 | 1,943,962 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $481,489,845 | 1,969,767 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $241,193,809 | 1,165,469 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $210,844,048 | 1,137,116 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $162,333,382 | 1,062,739 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $178,924,776 | 1,078,900 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $163,099,109 | 1,127,777 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $189,488,817 | 1,169,251 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $177,426,108 | 1,213,917 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $202,717,004 | 1,281,478 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $207,139,590 | 1,321,549 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $212,658,558 | 1,365,384 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $227,404,286 | 1,373,878 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $223,669,495 | 1,443,029 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $259,083,545 | 1,466,649 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $237,320,096 | 1,452,743 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $255,531,147 | 1,439,531 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $249,368,458 | 1,407,033 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $238,920,809 | 1,396,626 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $223,163,768 | 1,381,819 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $225,693,470 | 1,369,998 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $235,142,447 | 1,430,742 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $219,614,819 | 1,395,443 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $206,551,943 | 1,387,372 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $192,264,695 | 1,367,167 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $171,856,617 | 1,310,582 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||